尼尔雌醇和左炔诺孕酮对人成骨肉瘤 MG-63细胞株雌激素受体亚型的作用

目的：观察不同浓度的尼尔雌醇(NYL)和左炔诺孕酮(LNG)对人成骨肉瘤MG-63细胞株ERα和ERβ表达的作用，探讨旁分泌效应对ERα和ERβ基因表达的影响。方法：人成骨肉瘤MG-63细胞株分为（1）空白对照组：用含1% BSA无血清MEM培养液培养48 h；（2）阳性对照组：培养液中加入10-8 mol/L的17β-estradiol (E2) 培养48 h；（3）药物处理组：培养液中分别加入10-10，10-8，10-6 mol/L的NYL或LNG培养48 h；（4）药物处理+换液组：培养液中分别加入10-10 mol/L的NYL或10-8 mol/L LNG培养48 h，每12 h更换新的含有相应药物的培养液。用半定量RT-PCR检测各组细胞ERα和ERβmRNA的表达。结果：NYL及LNG均能诱导ERα和ERβ亚型mRNA表达上调，诱导ERαmRNA表达的最强作用浓度均为10-6 mol/L。NYL，LNG对ERβ mRNA表达最强作用浓度分别为10-10，10-8 mol/L。每12 h更换干预培养液对ERα表达无影响，但可抑制ERβ的表达。结论：NYL和LNG均可诱导MG-63细胞株ERα和ERβ mRNA表达上调，且2种亚型的表达存在相互制约关系；在NYL和LNG诱导ER亚型表达上调过程中ERβ的表达可能受到旁分泌作用的影响。     

18F-FDG PET/CT在黑色素瘤中的应用价值

目的 探讨18F-脱氧葡萄糖(FDG)PET/CT显像在黑色素瘤诊断、临床分期及监测治疗后肿瘤复发与转移灶中的应用价值.方法 黑色素瘤患者61例,均进行18F-FDG PET/CT全身显像.所有PET、CT及PET/CT融合图像均通过融合软件进行帧对帧对比分析.肿瘤病灶根据病理学检查、多种影像学检查及临床随访结果诊断.结果 18F-FDG PET/CT显像对黑色素瘤病灶检出的灵敏度、特异性和准确性分别为90.9%(40/44)、88.2%(15/17)和90.2%(55/61).其中12例治疗前患者中,18F-FDG PET/CT显像诊断的灵敏度为83.3%(10/12).在黑色素瘤病灶局部切除、尚未进行其他治疗的9例患者中,5例残余病灶18F-FDG PET/CT显像检出3例;4例远处转移灶患者全被检出,提高了临床分期,改变了治疗方案.首先发现转移性黑色素瘤病灶并且手术切除后,寻找原发灶的7例患者中,18F-FDG PET/CT检出原发灶2例,4例其他转移灶全被检出.黑色素瘤患者根治术后监测肿瘤复发或转移患者33例,18F-FDG PET/CT显像灵敏度、特异性和准确性分别为100.0%(19/19)、85.7%(12/14)和93.9%(31/33).与同期临床其他影像学检查比较,18F-FDG PET/CT显像发现更多,33例患者中,16例(48.5%)病灶提高临床分期;7例(21.2%)排除可疑病灶,降低临床分期;10例(30.3%)检出病灶与临床一致.结论 18F-FDG PET/CT显像对于黑色素瘤的诊断,残余病灶、复发病灶及转移灶的检出,临床分期的明确具有重要价值.     

阿片受体对体外循环缺血再灌注损伤心肌的保护作用

目的 通过建立猪体外循环(CPB)心肌缺血再灌注(MI/R)模型对δ阿片受体激动剂脑腓肽(DADLE)介导的CPB MI/R损伤早期时相和后时相的心肌保护作用进行探讨,以期为临床心肌保护提供理论和实验依据.方法 将24只成年家猪随机分为对照组、早期时相和后时相组,每组8只常规建立CPB模型,主动脉阻断同时灌注改良St.Thomas停搏液.每组于CPB前、主动脉开放时、CPB结束时、停机后1、2 h检测冠状静脉窦血肌钙蛋白(TnT)含量,相应时间点监测左室舒张末期压(LVEDP)和左室内压最大变化速率(±ap/dt<,max>),于停机后2h取左心室心肌,进行心肌组织Gia蛋白的表达、PKC的表达和ATP含量的测定.并应用透射电镜观察心肌再灌注损伤超微结构的变化.结果 (1)和早期时相和后时相组相比,对照组心功能指标明显下降.(2)对照组的TnT较早期时相和后时相组明显升高,ATP含量明显降低.(3)和对照组相比,早期时相和后时相组Gin蛋白和PKC的表达更为明显.(4)透射电镜下早期时相和后时相组的心肌超微结构损伤均较对照组明显轻微.结论 (1)和CPB前1 h应用一次DADLE而产生的早期时相心肌保护作用相比,CPB前48 h和24 h两次应用DADLE引发的后时相心肌保护作用更为显著.(2)Gi蛋白-PKC途径可能是δ阿片受体介导的猪CPB NI/R损伤心肌保护中一条重要的信号传导途径.     

对原发性骨质疏松诊断的一些看法

原发性骨质疏松的诊断首先要除外继发性骨质疏松。后者包括的范围很广，内容也很多，需要广博的内科学基础和辨证的逻辑思维才能予以正确鉴别。骨密度检查只能作为一种参考，而不能作为诊断原发性骨质疏松的唯一依据。     

警惕下肢内固定术中主干动脉损伤

下肢骨折内固定术中动脉损伤很容易漏诊和延误治疗,并造成严重残废[1].2002年3月～2005年3月,笔者共收治4例下肢内固定术中并发主干动脉损伤病例.现报道并分析原因,旨在提高对这种损伤的警惕,最大限度地避免该并发症的发生.     

Combining microwave‐enhanced deuteriation reactions with parallel synthesis procedures

The development of combined microwave‐enhanced/parallel synthesis procedures and their application to the deuteriation of organic compounds via examples of solid‐state hydrogenation is reported. Other labelling procedures, such as solution state catalytic dehalogenations, hydrogenations as well as hydrogen isotope exchange reactions also benefit from the combined technology. Copyright © 2003 John Wiley & Sons, Ltd.     

2001年与2004年抗菌药物应用情况比较

目的　了解抗菌药物应用的基本情况。方法　将 2 0 0 1年 3月 14 3 0例住院患者病历与 2 0 0 4年 3月的 2 0 66例住院患者病历进行回顾性调查和对比分析。结果　 2 0 0 1年的 14 3 0例中有 948(66 3 % )例 ,和 2 0 0 4年的 2 0 66例有 10 60例 (5 1.3 % ) ,应用了抗菌药物。结论　定期检查考评 ,严格掌握用药指征 ,是加强抗菌药物应用管理的关键。     

Two novel gastric cancer-associated genes identified by differential display

AIM To clone novel gastric cancer-associated genes and investigate their roles in gastric cancer occurrence.METHODS A method called differential display was used which allows the identification of differentially expressed genes by using PAGE to display PCR-amplified cDNA fragments between gastric cancer cells and normal gastric mucosa cells. These fragments were cloned into plasmid vector pUC18. Homology analysis was made after sequencing these fragments.RESULTS Two novel genes were identified compared with sequences from GenBank. One was registered with the AD number AF 051783. In situ hybridization showed that these two novel genes expressed specifically in gastric cancer tissues.CONCLUSION The two novel genes obtained by differential display were confirmed to be gastric cancer-associated genes using in situ hybridization.     

Human T cell responses to recombinant mite antigens of Dermatophagoides farinae

We studied T cell responses to four glutathione S transferase (GST)-fused mite antigens prepared in our laboratory using peripheral blood lymphocytes from mite-sensitive patients with bronchial asthma. Of the four recombinant antigens, purified GST-Mag3 had the strongest ability to cause patients' lymphocytes to proliferate, and its potency was almost comparable to that of crude mite bodies (Dfb) and faeces (Dff) antigens and a purified major antigen, Der f 2. The responder lymphocytes were mainly T cells, because the proliferative response was depleted by the treatment of lymphocytes with anti-CD3 antibody and complement, but not with anti-CD20 antibody and complement. The responsiveness of lymphocytes to GST-Mag3 correlated with that to Der f 2, but GST-Mag3 displayed slightly higher activity to stimulate lymphocytes than Der f 2. Simultaneously, the levels of Dff- and GST-Mag3-specific IgE antibodies correlated with the responsiveness of lymphocytes to GST-Mag3. These results suggest that Mag3 is a new valuable antigen for the response of T cell proliferation in mite-sensitive patients.